Financial Advantage, Inc. Bristol Myers Squibb CO Transaction History

Financial Advantage, Inc.

$65.1 Million
Q3 2023

A detailed history of Financial Advantage, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Advantage, Inc. holds 51,049 shares of BMY stock, worth $2.95 Million. This represents 4.55% of its overall portfolio holdings.

Number of Shares

51,049

Previous 84,230 39.39%

Holding current value

$2.95 Million

Previous $5.39 Million 45.01%

% of portfolio

4.55%

Previous 4.82%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $1.92 Million - $2.15 Million	-33,181 Reduced 39.39%	51,049 $2.96 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $70,272 - $78,026	1,103 Added 1.33%	84,230 $5.39 Million
Q1 2023 May 03, 2023	BUY	$65.71 - $74.53 $5,585 - $6,335	85 Added 0.1%	83,127 $5.76 Million
Q4 2022 Jan 26, 2023	SELL	$68.48 - $81.09 $119,634 - $141,664	-1,747 Reduced 2.06%	83,042 $0
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $6 - $3,995	52 Added 0.06%	84,789 $6.03 Million
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $55,990 - $61,664	771 Added 0.92%	84,737 $6.52 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $46,294 - $55,511	753 Added 0.9%	83,966 $6.13 Million
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $118,683 - $138,356	2,213 Added 2.73%	83,213 $5.19 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $47,691 - $55,863	806 Added 1.01%	81,000 $4.79 Million
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $118,743 - $129,311	-1,918 Reduced 2.34%	80,194 $5.36 Million
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $45,810 - $51,523	772 Added 0.95%	82,112 $5.18 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $310,352 - $351,686	-5,375 Reduced 6.2%	81,340 $5.05 Million
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $1.61 Million - $1.78 Million	-28,031 Reduced 24.43%	86,715 $5.23 Million
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $85,793 - $100,300	-1,565 Reduced 1.35%	114,746 $6.75 Million
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $112,937 - $164,124	-2,434 Reduced 2.05%	116,311 $6.48 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $2.22 Million - $2.9 Million	45,144 Added 61.34%	118,745 $7.62 Million
Q3 2019 Oct 23, 2019	BUY	$42.77 - $50.71 $20,828 - $24,695	487 Added 0.67%	73,601 $3.73 Million
Q2 2019 Jul 23, 2019	BUY	$44.62 - $49.34 $43,504 - $48,106	975 Added 1.35%	73,114 $3.32 Million
Q1 2019 Apr 17, 2019	BUY	$45.12 - $53.8 $3.25 Million - $3.88 Million	72,139 New	72,139 $3.44 Million
Q4 2017 Feb 07, 2018	SELL	$59.94 - $65.35 $26,973 - $29,407	-450 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $24,853 - $28,683	450	450 $29,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advantage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advantage, Inc. with notifications on news.

Account

Financial Advantage, Inc. Bristol Myers Squibb CO Transaction History